Eli Lilly and Co. is more than 15 years late to the game in the world of diabetes drugs. And it isn’t bringing much that doctors and patients haven’t already seen. Still, that might be good enough to make a few billion a year.
With recent attention focused on hospital prices, WellPoint and its peers have been enjoying a nice break from their long-running status as Public Enemy No. 1 in the nation’s health care debate. They shouldn’t expect it to last.
Local providers will increasingly look for help from IT firms like Indigo Biosystems Inc. and VoCare Inc. as part of a coming wave of health IT innovation that is likely to mirror the IT revolution that began 30 years ago.
A new recommendation from the Medicare Payment Advisory Commission, if enacted, would likely end one of the ways Indianapolis-area hospitals have generated healthy revenue from their recent spree of physician acquisitions.
To get control of health care spending, prominent health policy wonks are calling for new rules requiring hospitals and insurers to raise the ‘veil of secrecy’ they have thrown over their prices for decades.
New analysis shows Obamacare would cut state’s uninsured rolls 49 percent, compared with just 18 percent if Gov. Mike Pence opts out of a Medicaid expansion.
Whenever a new report claims hospitals are charging too much, a stock set of defenses comes out. But hospitals are cutting prices and expenses as we speak, undermining those arguments.
The real test of so-called narrow network health plans will come not with Obamacare's exchanges, but with employers, who control a far bigger slice of the health benefits pie and have been highly reluctant to limit their workers' choice of hospitals and doctors.
The real test of so-called narrow network health plans will come not with Obamacare’s exchanges, which cater to individuals, but with employers, who control a far bigger slice of the health benefits pie and have highly reluctant to limit their workers' choice of hospitals and doctors.
One month into Joe Swedish's tenure as CEO of WellPoint Inc., he and the communications staff set up an interview with me. That was quite different from my experience with Angela Braly, who declined all of my interview requests in her 63 months as CEO.
Welcome to The Dose, a blog about the business of health care. As your host, J.K. Wall, I'll be writing about the most interesting new developments I see at hospitals, doctors, insurers, employers, patients, drugmakers, device companies and medical researchers around Indianapolis and around the country.
In the first post on my new blog, The Dose, I explain why the recently released Medicare charge data are meaningless for everyone but uninsured patients.
